US Patent 8003794 (
Patent 8003794 was granted and assigned to Progenics Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+150 characters)
Article
Patent abstract
This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Christopher Verbicky0
Howard Wagoner0
Stephen Andruski0
Suketu P. Sanghvi0
Thomas A. Boyd0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08003794 ( US Patent 8003794 (
Infobox
Patent Number
08003794
Patent Number
8003794
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08003794 (
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08003794
Date of patent
August 23, 2011
Patent application number
12460507
Date Filed
July 20, 2009
Patent primary examiner
Find more entities like US Patent 8003794 (
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
